GlassScriptPhysician profile
Marvin James Derrick
NPI 1497855886
$5,587.45
in general payments reported to CMS, 2019-2025
16 companies · $611 in 2025
The $611 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $598 · 2021: $1,517 · 2022: $226 · 2023: $824 · 2024: $1,296 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,651 · Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,651.46 |
| Food and Beverage | $1,079.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,291.02 | 2019-2025 | Advantagerib, Venapax |
| Atricure, INC. | $1,231.49 | 2021-2023 | |
| Edwards Lifesciences Corporation | $821.72 | 2020-2025 | Inspiris Resilia Aortic Valve |
| Covidien LP | $290.23 | 2019 | |
| Abiomed | $232.55 | 2023 | Impella |
| Abbott Laboratories | $165.70 | 2022 | |
| Kerecis Limited | $114.34 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ethicon US, LLC | $112.36 | 2025 | Echelon Flex |
| Haemonetics Corporation | $91.55 | 2023 | Teg6s Hemostasis System |
| Astrazeneca Pharmaceuticals LP | $80.58 | 2025 | Farxiga, Wainua |
| Pfizer INC. | $47.90 | 2025 | |
| Getinge USA Sales, LLC | $27.04 | 2019-2021 | |
| Davol INC. | $23.33 | 2021 | |
| Scpharmaceuticals INC. | $20.65 | 2025 | |
| Philips North America LLC | $19.21 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.78 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Derrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.